NO

NovMetaPharma Co., Ltd.

Develops first-in-class drugs and supplements for metabolic and fibrotic diseases.

229500 | KO

Overview

Corporate Details

ISIN(s):
N/A
LEI:
Country:
South Korea
Address:
서울특별시 강남구 언주로 727 13층 (논현동, 트리스빌딩), 강남구
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

NovMetaPharma Co., Ltd. is a biopharmaceutical company specializing in the research, development, and commercialization of first-in-class drugs for metabolic and fibrotic diseases. The company focuses on creating novel treatments with differentiated mechanisms to address significant unmet medical needs. Its core pipeline includes therapeutic candidates for conditions such as type 2 diabetes, obesity, chronic kidney disease, and fibrosis, with lead assets including Cyclo-Z and CHP. In addition to its primary focus on drug development, the company also develops health supplements and sells related raw materials.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-05-15 00:00
Regulatory News Service
기업설명회(IR)개최결과
Korean 6.6 KB
2025-05-13 00:00
Regulatory News Service
특허권취득(자율공시)
Korean 4.8 KB
2025-04-29 00:00
Report Publication Announcement
기업설명회(IR)개최
Korean 7.0 KB
2025-03-31 00:00
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
Korean 170.5 KB
2025-03-25 00:00
Share Issue/Capital Change
증권발행결과(자율공시)
Korean 5.3 KB
2025-03-24 00:00
Post-Annual General Meeting Information
정기주주총회결과
Korean 20.3 KB
2025-03-24 00:00
Share Issue/Capital Change
주식매수선택권부여에관한신고
Korean 22.1 KB
2025-03-14 00:00
Audit Report / Information
사업보고서 (2024.12)
Korean 361.6 KB
2025-03-13 00:00
Audit Report / Information
감사보고서제출
Korean 9.4 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집결의
Korean 11.0 KB
2025-03-07 00:00
Pre-Annual General Meeting Information
주주총회소집공고
Korean 238.9 KB
2025-03-06 00:00
Share Issue/Capital Change
주요사항보고서(유상증자결정)
Korean 66.1 KB
2025-02-05 00:00
Regulatory News Service
특허권취득(자율공시)
Korean 5.6 KB

Automate Your Workflow. Get a real-time feed of all NovMetaPharma Co., Ltd. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for NovMetaPharma Co., Ltd. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
2cureX AB Logo
Predicts cancer drug response using 3D tumoroid tests to guide personalized oncology.
Sweden 2CUREX
4BASEBIO PLC Logo
Manufactures GMP-compliant synthetic DNA for advanced therapies, vaccines, and cell/gene therapies.
United Kingdom 4BB
4SC AG Logo
Developing small-molecule epigenetic drugs for high-need cancer indications.
Germany VSC
Abera Bioscience AB Logo
Develops next-gen mucosal vaccines using its OMV platform, with a lead pneumococcal candidate.
Sweden ABERA
ABINGDON HEALTH PLC Logo
A CDMO for lateral flow rapid tests, providing end-to-end services and its own branded products.
United Kingdom ABDX
ABIONYX Pharma Logo
Biotech developing lipid-based therapies for rare renal and ophthalmological diseases.
France ABNX
Abliva Logo
Develops clinical-stage medicines for rare primary mitochondrial diseases to restore cell function.
Sweden ABLI
AB Science Logo
Develops protein kinase inhibitors for oncology, neuro, and inflammatory diseases.
France AB
Access Bio, Inc. Logo
Develops and manufactures rapid diagnostic tests for infectious diseases for global health.
United States of America 950130
Active Biotech Logo
Develops immunology-based drugs for cancer and inflammatory diseases with high unmet medical need.
Sweden ACTI

Talk to a Data Expert

Have a question? We'll get back to you promptly.